MedPath

Electromagnetic Field Therapy to Improve Healing of Chronically Venous Ulcer

Conditions
Venous Ulcer Pain
Chronic Venous Hypertension With Ulcer and Inflammation
Interventions
Device: Active Pulsed Electro-Magnetic Field (PEMF)
Device: Placebo Pulsed Electro-Magnetic Field (PEMF)
Registration Number
NCT01561170
Lead Sponsor
Northern Orthopaedic Division, Denmark
Brief Summary

Chronically venous ulcer in lower extremities is a permanent and disabling disease. Venous insufficience is the main cause of chronic ulcer. There is a high prevalence and frequency of the disease, primarily among elderly people. Recently, electromagnetic field therapy has been tested on various diseases in musculoskeletal system with a beneficial effect. In recent years, there has been an increasing interest in using electromagnetic field therapy to treat chronically venous ulcer.

The hypothesis of the investigators is that the electronic magnetic field therapy improves the healing process and reduces pain for patients suffering from chronically venous ulcer. The investigators assume that the bioactivity is affected by a cellular response which affects the DNA synthesis, transcription og protein synthesis.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Patients who suffer from ulcer in lower extremities
  • Patients who suffer from venous insufficience detected by duplex scanning or by a pressure on digits > 40 mmHg
  • Patients with a regular need of compression stockings
  • Age > 18 years
Exclusion Criteria
  • Age < 18 years
  • Unability to read or understand Danish
  • Patients who suffer from manifest neoplastic disorder

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Chronically venous ulcerActive Pulsed Electro-Magnetic Field (PEMF)A group of 36 patients
Chronically venous ulcerPlacebo Pulsed Electro-Magnetic Field (PEMF)A group of 36 patients
Primary Outcome Measures
NameTimeMethod
Reduction of ulcerous area.3 months

Measurement of ulcerous area in order to assessing the effect of the healing process.

Secondary Outcome Measures
NameTimeMethod
Pain reduction in proportion to Visual Analogue Scale (VAS).3 months

The pain reduction will be measured by VAS and an analysis of the medication between the two group of patients will be carried out in order to measure quality of life, adverse effects, ulceration, granulation tissue etc.

Trial Locations

Locations (1)

Northern Orthopaedic Division, Aalborg University Hospital,

🇩🇰

Aalborg, Denmark

© Copyright 2025. All Rights Reserved by MedPath